Terms: = Germ cell tumor AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
2653 results:
1. Multiple Primary Melanoma Associated with cdkn2a Mutation-Case Report and Review of the Literature.
Nurla LA; Aşchie M; Cozaru GC; Boșoteanu M
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792946
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma cells.
Cappabianca L; Ruggieri M; Sebastiano M; Sbaffone M; Martelli I; Ruggeri P; Di Padova M; Farina AR; Mackay AR
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791513
[TBL] [Abstract] [Full Text] [Related]
3. Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases.
Vizcaino MA; Giannini C; Lalich D; Nael A; Jenkins RB; Tran Q; Orr BA; Abdullaev Z; Aldape K; Vaubel RA
J Neuropathol Exp Neurol; 2024 May; 83(6):416-424. PubMed ID: 38699943
[TBL] [Abstract] [Full Text] [Related]
4. Association of Clinical, tumor, and Treatment Characteristics With Seizure Control in Patients With
Bruno F; Pellerino A; Conti Nibali M; Pronello E; Cofano F; Rossi M; Levis M; Bertero L; Soffietti R; Cassoni P; Garbossa D; Bello L; Rudà R
Neurology; 2024 May; 102(10):e209352. PubMed ID: 38684041
[TBL] [Abstract] [Full Text] [Related]
5. [Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for cdkn2a homozygous deletion in brain tumors].
Wang SN; Wang W; Zhang XW; Zhang YQ; Xiong YL; Liu L; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):439-445. PubMed ID: 38678323
[No Abstract] [Full Text] [Related]
6. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
7. De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression.
Tangudu NK; Buj R; Wang H; Wang J; Cole AR; Uboveja A; Fang R; Amalric A; Yang B; Chatoff A; Crispim CV; Sajjakulnukit P; Lyons MA; Cooper K; Hempel N; Lyssiotis CA; Chandran UR; Snyder NW; Aird KM
Cancer Res Commun; 2024 May; 4(5):1174-1188. PubMed ID: 38626341
[TBL] [Abstract] [Full Text] [Related]
8. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
[TBL] [Abstract] [Full Text] [Related]
9. Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype.
Nassiri F; Ajisebutu A; Patil V; Mamatjan Y; Liu J; Wang JZ; Voisin MR; Nejad R; Mansouri S; Karimi S; Chakravarthy A; Chen E; De Carvalho DD; Aldape K; Zadeh G
Acta Neuropathol; 2024 Apr; 147(1):68. PubMed ID: 38583102
[TBL] [Abstract] [Full Text] [Related]
10. OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses.
Zheng Y; Wang X; Ji Q; Fang A; Song L; Xu X; Lin Y; Peng Y; Yu J; Xie L; Chen F; Li X; Zhu S; Zhang B; Zhou L; Yu C; Wang Y; Wang L; Hu H; Zhang Z; Liu B; Wu Z; Li W
Cancer Lett; 2024 May; 589():216834. PubMed ID: 38537773
[TBL] [Abstract] [Full Text] [Related]
11. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
12. p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice.
Hill RJ; Bona N; Smink J; Webb HK; Crisp A; Garaycoechea JI; Crossan GP
Nat Commun; 2024 Mar; 15(1):2518. PubMed ID: 38514641
[TBL] [Abstract] [Full Text] [Related]
13. Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example.
Evans AR; Prather KY; Battiste J; Fung KM; Dunn IF; Graffeo CS
World Neurosurg; 2024 May; 185():e1093-e1100. PubMed ID: 38490447
[TBL] [Abstract] [Full Text] [Related]
14. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
[TBL] [Abstract] [Full Text] [Related]
15. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
16. cdkn2a promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine.
Wang J; Xi YF; Zhao Q; Guo JH; Zhang Z; Zhang MB; Chang J; Wu YQ; Su W
Mol Biol Rep; 2024 Mar; 51(1):385. PubMed ID: 38438773
[TBL] [Abstract] [Full Text] [Related]
17. METTL14-Mediated m6a Modification of cdkn2a Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway.
Chen J; Zeng B
Crit Rev Immunol; 2024; 44(3):89-98. PubMed ID: 38421707
[TBL] [Abstract] [Full Text] [Related]
18. Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
Xi S; Jiang S; Li H; Huang Q; Lu J; Zhang X; Li Z; Zeng J
Int J Cancer; 2024 Jul; 155(1):172-183. PubMed ID: 38411299
[TBL] [Abstract] [Full Text] [Related]
19. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
[TBL] [Abstract] [Full Text] [Related]
20. Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR.
Dobre EG; Nichita L; Popp C; Zurac S; Neagu M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396984
[TBL] [Abstract] [Full Text] [Related]
[Next]
